ASPECT BIOSYSTEMS LTD.

In News

Novo Nordisk expands diabetes cell therapy partnership with Aspect Biosystems - Reuters

Reuters - Jan 20, 2026

Aspect Biosystems expands partnership with Novo Nordisk to develop diabetes treatment - The Globe and Mail

The Globe and Mail - Jan 20, 2026

Novo Nordisk and Aspect Biosystems expand collaboration on diabetes research - PMLiVE

PMLiVE - Jan 29, 2026

Feds invest $79 million in Aspect Biosystems to develop 3D-printed tissue treatment - BetaKit

BetaKit - Apr 02, 2026

Aspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics - Business Wire

Business Wire - Jan 08, 2025

Aspect Biosystems secures $79-million in federal funding to advance 3-D tissue printing technology - The Globe and Mail

The Globe and Mail - Apr 02, 2026

Aspect Biosystems and Novo Nordisk enter partnership to - GlobeNewswire

GlobeNewswire - Apr 12, 2023

Aspect Biosystems secures $115m to develop tissue therapeutics - Pharmaceutical Technology

Pharmaceutical Technology - Jan 09, 2025

Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes - Yahoo Finance UK

Yahoo Finance UK - Jan 20, 2026

Vancouver biotech firm Aspect Biosystems raises US$115M - Business in Vancouver

Business in Vancouver - Jan 08, 2025

Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada and British Columbia to Advance Development of Bioprinted Tissue Therapeutics - Business Wire

Business Wire - Jul 10, 2024

Novo Nordisk divests cell technology rights in new collaboration - medwatch.com

medwatch.com - Jan 21, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment